Macrocycle Compounds
Growing interest towards medium- and large-sized macrocycles closely linked with the field of protein-protein interactions (PPI) as promising therapeutics targets.
ChemDiv used two methodologies for design and synthesis of macrocyclic peptidomimetic library.
One of them includes ring expansion employing Bormann-Wasserman strategy (BWS) and allows synthesising 10-12-membered lactams. This gives us access to unique functionally enriched, spiro and fused scaffolds.
The other one is based on click-macrocyclization of linear peptidomimetics bearing acetylene and azide functionalities at the ends to provide 14-22 membered macrocyclic peptidomimetics.
That allowed us to obtain novel, IP clean, diverse set of macrocyclic scaffolds that we offer for synthetic proposal.
Please contact us at chemdiv@chemdiv.com to obtain database of novel scaffolds for evaluation and discussion of final macrocycles compounds for production.
Macrocyclic Peptidomimetics
Our Goals:
-
The scaffolds and final compounds should be peptide mimetics;
-
The scaffolds should have at least two points of diversification, preferably in peptoid moiety;
-
The scaffolds and final compounds should be single diastereomers and, optionally, single
-
enantiomers with known configuration;
-
Selected synthetic tool for macrocyclization should be high yielding, preferably applicable for
-
liquid phase synthesis (LPS) and, optionally, for solid phase synthesis (SPS) if LPS fails to provide
-
target macrocycles in reasonable yields;
-
Reported data about structural features that are able to improve cell permeability for macrocyclic
-
peptide mimetics should be considered in the library design.
Synthetic Tool Selection:
-
Click-macro-cyclization (CMC) has obvious advantages if compared to other most used approaches such as macro-lactamization or RCM.
-
CMC is less sensitive in relation to size of cycle formed;
-
CMC is highly region-controlled with no stereo-chemical impact (in contrast to MCR that usually lead to
-
formation of cis- and trans-isomers in various ratio);
-
Triazole ring formed as a result of CMC is pharmacologically relevant: to the best of our knowledge at least no negative records for this structural moiety have been published so far;
-
There are numerous commercially/synthetically available bifunctional intermediates (azides, alkynes)
-
compatible with peptide synthesis to form linkers at CMC-step with variable linker (macrocycle formed)
-
size;
-
CMC tolerates many functional groups in pre-CMC intermediates;
-
CMC is less sensitive in relation to stereochemistry of peptoid moiety (in contrast to macro-lactamization
-
that often requires opposite configuration for amino acids to be coupled at the macrocycle formation step).
Despite obvious advantages, some issues are still actual for CMC:
-
High risk of di-, tri-meric (and even more) macrocycles formation in both, LPS and SPS.
-
High dilution technique is required at CMC-step; however, it does not guarantee only monomer cycle formation
-
Success or failure of each specific scaffold synthesis becomes known only at very late steps of the challenging multi-step synthesis
Nevertheless, our experience on validated and pre-validated series allows us to predict the most acceptable linkers and choose preferable CMC conditions to minimize mentioned side reactions and therefore to make the chemistry feasible in liquid phase.